These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12135478)
1. Ruk is ubiquitinated but not degraded by the proteasome. Verdier F; Valovka T; Zhyvoloup A; Drobot LB; Buchman V; Waterfield M; Gout I Eur J Biochem; 2002 Jul; 269(14):3402-8. PubMed ID: 12135478 [TBL] [Abstract][Full Text] [Related]
2. SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion. Schmidt MHH; Chen B; Randazzo LM; Bogler O J Cell Sci; 2003 Jul; 116(Pt 14):2845-55. PubMed ID: 12771190 [TBL] [Abstract][Full Text] [Related]
3. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma. Mayevska O; Shuvayeva H; Igumentseva N; Havrylov S; Basaraba O; Bobak Y; Barska M; Volod'ko N; Baranska J; Buchman V; Drobot L Exp Oncol; 2006 Dec; 28(4):275-81. PubMed ID: 17285110 [TBL] [Abstract][Full Text] [Related]
4. Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein. Gout I; Middleton G; Adu J; Ninkina NN; Drobot LB; Filonenko V; Matsuka G; Davies AM; Waterfield M; Buchman VL EMBO J; 2000 Aug; 19(15):4015-25. PubMed ID: 10921882 [TBL] [Abstract][Full Text] [Related]
5. CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes. Tossidou I; Teng B; Drobot L; Meyer-Schwesinger C; Worthmann K; Haller H; Schiffer M J Biol Chem; 2010 Aug; 285(33):25285-95. PubMed ID: 20457601 [TBL] [Abstract][Full Text] [Related]
6. Adaptor protein Ruk/CIN85 is associated with a subset of COPI-coated membranes of the Golgi complex. Havrylov S; Ichioka F; Powell K; Borthwick EB; Baranska J; Maki M; Buchman VL Traffic; 2008 May; 9(5):798-812. PubMed ID: 18266907 [TBL] [Abstract][Full Text] [Related]
7. The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases. Sanjay A; Horne WC; Baron R Sci STKE; 2001 Nov; 2001(110):pe40. PubMed ID: 11724969 [TBL] [Abstract][Full Text] [Related]
8. The adaptor molecule CIN85 regulates Syk tyrosine kinase level by activating the ubiquitin-proteasome degradation pathway. Peruzzi G; Molfetta R; Gasparrini F; Vian L; Morrone S; Piccoli M; Frati L; Santoni A; Paolini R J Immunol; 2007 Aug; 179(4):2089-96. PubMed ID: 17675467 [TBL] [Abstract][Full Text] [Related]
9. Multiple domains of Ruk/CIN85/SETA/CD2BP3 are involved in interaction with p85alpha regulatory subunit of PI 3-kinase. Borthwick EB; Korobko IV; Luke C; Drel VR; Fedyshyn YY; Ninkina N; Drobot LB; Buchman VL J Mol Biol; 2004 Oct; 343(4):1135-46. PubMed ID: 15476827 [TBL] [Abstract][Full Text] [Related]
10. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. Rao N; Ghosh AK; Ota S; Zhou P; Reddi AL; Hakezi K; Druker BK; Wu J; Band H EMBO J; 2001 Dec; 20(24):7085-95. PubMed ID: 11742985 [TBL] [Abstract][Full Text] [Related]
11. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Haglund K; Shimokawa N; Szymkiewicz I; Dikic I Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12191-6. PubMed ID: 12218189 [TBL] [Abstract][Full Text] [Related]
12. Organization of the mouse Ruk locus and expression of isoforms in mouse tissues. Buchman VL; Luke C; Borthwick EB; Gout I; Ninkina N Gene; 2002 Jul; 295(1):13-17. PubMed ID: 12242006 [TBL] [Abstract][Full Text] [Related]
13. Studying protein isoforms of the adaptor SETA/CIN85/Ruk with monoclonal antibodies. Finniss S; Movsisyan A; Billecke C; Schmidt M; Randazzo L; Chen B; Bögler O Biochem Biophys Res Commun; 2004 Dec; 325(1):174-82. PubMed ID: 15522216 [TBL] [Abstract][Full Text] [Related]
14. C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer. Hattori T; Ohoka N; Inoue Y; Hayashi H; Onozaki K Oncogene; 2003 Mar; 22(9):1273-80. PubMed ID: 12618752 [TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-proteasome pathway is required for the function of the viral VP16 transcriptional activation domain. Zhu Q; Yao J; Wani G; Chen J; Wang QE; Wani AA FEBS Lett; 2004 Jan; 556(1-3):19-25. PubMed ID: 14706819 [TBL] [Abstract][Full Text] [Related]
16. Promotion of G alpha i3 subunit down-regulation by GIPN, a putative E3 ubiquitin ligase that interacts with RGS-GAIP. Fischer T; De Vries L; Meerloo T; Farquhar MG Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8270-5. PubMed ID: 12826607 [TBL] [Abstract][Full Text] [Related]
17. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination. Alwan HA; van Zoelen EJ; van Leeuwen JE J Biol Chem; 2003 Sep; 278(37):35781-90. PubMed ID: 12829707 [TBL] [Abstract][Full Text] [Related]